BULLOCK LAWRENCE E 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Aug 9, 2017
Insider Transaction Report
Form 4
BULLOCK LAWRENCE E
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2017-08-03+4,168→ 4,168 totalExercise: $4.50Exp: 2027-08-03→ Common Stock (4,168 underlying)
Footnotes (1)
- [F1]Option became exercisable for 25% on August 3, 2017, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments on the last day of each calendar month beginning August 31, 2017 and ending October 31, 2017, as long as Mr. Bullock continues to be employed with Applied Genetic Technologies Corporation and with no further vesting after his employment ends.